Castle biosciences strengthens commitment to esophageal cancer awareness through collaborative partnerships

Friendswood, texas, april 08, 2025 (globe newswire) -- castle biosciences, inc. (nasdaq: cstl), a company improving health through innovative tests that guide patient care, is supporting key educational programs and initiatives throughout the month of april in recognition of esophageal cancer awareness month. the company is proudly collaborating with the esophageal cancer action network (ecan), the american foregut society (afs) and the gut doctor podcastllc to promote esophageal cancer prevention, education and advocacy.
CSTL Ratings Summary
CSTL Quant Ranking